PRTN3 and rheumatoid arthritis: Plenty of autoantibodies have been identified as markers of RA, including rheumatoid factor (RF) and antibodies against post-translational modified proteins [such as anti-citrullinated protein autoantibody (ACPA)] and carbamylation, which may form immune complexes within the joint and lead to the aggregation of immune cells (42).